Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease

C Huisman, H M van der Straaten, M R Canninga-van Dijk, R Fijnheer, L F Verdonck, C Huisman, H M van der Straaten, M R Canninga-van Dijk, R Fijnheer, L F Verdonck

Abstract

Lung injury limits the success of allogeneic stem cell transplantation (SCT). The overall incidence varies from 30 to 50% and non-infectious causes occur in one-third to one-half of these. We reviewed pulmonary complications in 369 consecutive patients who received a partially T-cell-depleted myeloablative allogeneic hematopoietic SCT at our institution between 1993 and 2003. All patients were treated uniformly with cyclophosphamide followed by total body irradiation. Control subjects were matched on sex, underlying diagnosis, age, type of transplantation and cytomegalovirus (CMV)-serostatus. Sixty-one patients (16.5%) developed pulmonary complications. Twenty-one patients (5.7%) developed infectious pneumonia. Forty patients developed non-infectious complications which were further subclassified as bronchiolitis obliterans (3.5%), bronchiolitis obliterans-organizing pneumonia (0.5%), diffuse alveolar hemorrhage (0.8%), idiopathic pneumonia syndrome (5.5%) or mixed etiology (0.5%). Acute graft-versus-host disease (GVHD) > or =grade II was significantly more common in pulmonary patients than in the controls (36/61 versus 22/61 patients, P=0.02). There was no significant difference in the incidence of chronic GVHD (P=0.09). CMV reactivation was significantly more frequent in patients with lung injury (P=0.02). Median survival was 41 weeks for the pulmonary patients and 350 weeks for the controls (P=0.001). Altogether, the incidence of pulmonary complications is low after T-cell-depleted SCT and is associated with acute GVHD and CMV reactivation.

References

    1. Breuer R, Lossos IS, Berkman N, Or R. Pulmonary complications of bone marrow transplantation. Respir Med. 1993;87:571–579.
    1. Cordonnier C, Bernaudin JF, Bierling P, Huet Y, Vernant JP. Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients. Cancer. 1986;58:1047–1054. doi: 10.1002/1097-0142(19860901)58:5<1047::AID-CNCR2820580512>;2-Y.
    1. Krowka MJ, Rosenow EC, III, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest. 1985;87:237–246. doi: 10.1378/chest.87.2.237.
    1. Afessa B, Tefferi A, Litzow MR, Krowka MJ, Wylam ME, Peters SG. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med. 2002;166:641–645. doi: 10.1164/rccm.200112-141CC.
    1. Chen CS, Boeckh M, Seidel K, Clark JG, Kansu E, Madtes DK. Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003;32:515–522. doi: 10.1038/sj.bmt.1704162.
    1. Freudenberger TD, Madtes DK, Curtis JR, Cummings P, Storer PE, Hackman RC. Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood. 2003;102:3822–3828. doi: 10.1182/blood-2002-06-1813.
    1. Fukuda T, Hackman RC, Guthrie KA, Sandmeier BM, Boeckh M, Maris MB. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood. 2003;102:2777–2785. doi: 10.1182/blood-2003-05-1597.
    1. Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7:223–229. doi: 10.1053/bbmt.2001.v7.pm11349809.
    1. Kantrow SP, Hackman RC, Boeckh M, Myerson D, Crawford SW. Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation. 1997;63:1079–1086. doi: 10.1097/00007890-199704270-00006.
    1. Nusair S, Breuer R, Shapira MY, Berkman N, Or R. Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation. Eur Respir J. 2004;23:440–445. doi: 10.1183/09031936.04.00053004.
    1. Palmas A, Tefferi A, Myers JL, Scott JP, Swensen SJ, Chen MG. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol. 1998;100:680–687. doi: 10.1046/j.1365-2141.1998.00617.x.
    1. Sakaida E, Nakaseko C, Harima A, Yokota A, Cho R, Saito Y. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood. 2003;102:4236–4242. doi: 10.1182/blood-2002-10-3289.
    1. Savani BN, Montero A, Wu C, Nlonda N, Read E, Dunbar C. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:223–230. doi: 10.1016/j.bbmt.2004.12.328.
    1. Wong R, Rondon G, Saliba RM, Shannon VR, Giralt SA, Champlin RE. Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer. Bone Marrow Transplant. 2003;31:1157–1163. doi: 10.1038/sj.bmt.1704141.
    1. Clark JG, Hansen JA, Hertz MI, Parkman R, Jensen L, Peavy HH. NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis. 1993;147:1601–1606. doi: 10.1164/ajrccm/147.6_Pt_1.1601.
    1. Crawford SW, Hackman RC. Clinical course of idiopathic pneumonia after bone marrow transplantation. Am Rev Respir Dis. 1993;147:1393–1400. doi: 10.1164/ajrccm/147.6_Pt_1.1393.
    1. Weiner RS, Bortin MM, Gale RP, Gluckman E, Kay HE, Kolb HJ. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med. 1986;104:168–175. doi: 10.7326/0003-4819-104-2-168.
    1. Cooke KR, Yanik G. Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease? Bone Marrow Transplant. 2004;34:753–765. doi: 10.1038/sj.bmt.1704629.
    1. Crawford SW, Clark JG. Bronchiolitis associated with bone marrow transplantation. Clin Chest Med. 1993;14:741–749.
    1. Holland HK, Wingard JR, Beschorner WE, Saral R, Santos GW. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood. 1988;72:621–627.
    1. Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;28:425–434. doi: 10.1038/sj.bmt.1703142.
    1. Weisdorf DJ. Diffuse alveolar hemorrhage: an evolving problem? Leukemia. 2003;17:1049–1050. doi: 10.1038/sj.leu.2402921.
    1. Verdonck LF, Dekker AW, de Gast GC, van Kempen ML, Lokhorst HM, Nieuwenhuis HK. Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood. 1994;83:3090–3096.
    1. Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE. Bone-marrow transplantation (second of two parts) N Engl J Med. 1975;292:895–902. doi: 10.1056/NEJM197504242921706.
    1. van Elden LJ, van Loon AM, van Alphen F, Hendriksen KA, Hoepelman AI, van Kraaij MG. Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction. J Infect Dis. 2004;189:652–657. doi: 10.1086/381207.
    1. van Kraaij MG, van Elden LJ, van Loon AM, Hendriksen KA, Laterveer L, Dekker AW. Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture. Clin Infect Dis. 2005;40:662–669. doi: 10.1086/427801.
    1. Wingard JR, Sostrin MB, Vriesendorp HM, Mellits ED, Santos GW, Fuller DJ. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation. 1988;46:61–65. doi: 10.1097/00007890-198807000-00010.
    1. Pecego R, Hill R, Appelbaum FR, Amos D, Bruckner CD, Feder A. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation. 1986;42:515–517. doi: 10.1097/00007890-198611000-00015.
    1. Breuer R, Or R, Lijovetzky G, Naparstek E, Engelhard D, Lafair J. Interstitial pneumonitis in T cell-depleted bone marrow transplantation. Bone Marrow Transplant. 1988;3:625–630.
    1. Clark JG, Schwartz DA, Flournoy N, Sullivan KM, Crawford SW, Thomas ED. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med. 1987;107:648–656. doi: 10.7326/0003-4819-107-5-648.
    1. Curtis DJ, Smale A, Thien F, Schwarer AP, Szer J. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995;16:169–173.
    1. Urbanski SJ, Kossakowska AE, Curtis J, Chan CK, Hutcheon MA, Hyland RH. Idiopathic small airways pathology in patients with graft-versus-host disease following allogeneic bone marrow transplantation. Am J Surg Pathol. 1987;11:965–971. doi: 10.1097/00000478-198712000-00007.
    1. Wyatt SE, Nunn P, Hows JM, Yin J, Hayes MC, Catovsky D. Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax. 1984;39:887–894. doi: 10.1136/thx.39.12.887.
    1. Beschorner WE, Saral R, Hutchins GM, Tutschka PJ, Santos GW. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants. N Engl J Med. 1978;299:1030–1036. doi: 10.1056/NEJM197811092991902.
    1. Sloane JP, Depledge MH, Powles RL, Morgenstern GR, Trickey BS, Dady PJ. Histopathology of the lung after bone marrow transplantation. J Clin Pathol. 1983;36:546–554. doi: 10.1136/jcp.36.5.546.
    1. Cooke KR, Krenger W, Hill G, Martin TR, Kobzik L, Brewer J. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood. 1998;92:2571–2580.
    1. Hildebrandt GC, Olkiewicz KM, Choi S, Corrion LA, Clouthier SG, Liu C. Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation. Blood. 2005;105:2249–2257. doi: 10.1182/blood-2004-08-3320.
    1. Yoshihara S, Tateishi U, Ando T, Kunitoh H, Suyama H, Onishi Y. Lower incidence of bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplant. 2005;35:1195–1200. doi: 10.1038/sj.bmt.1704985.
    1. Chien JW, Madtes DK, Clark JG. Pulmonary function testing prior to hematopoietic stem cell transplantation. Bone Marrow Transplant. 2005;35:429–435. doi: 10.1038/sj.bmt.1704783.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe